Showing 221 - 240 results of 354 for search '"survival analysis"', query time: 0.08s Refine Results
  1. 221

    A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis by Nasibeh Khayer, Samira Shabani, Maryam Jalessi, Mohammad Taghi Joghataei, Frouzandeh Mahjoubi

    Published 2025-01-01
    “…It suggests that Gins2 could serve as a potential upstream modulator in the PAM signaling pathway, playing a crucial role in the distant metastasis of HNSCC. In addition, survival analysis of significant switch genes indicated that two genes, C19orf33 and Usp13, may be especially important for prognostic purposes in HNSCC.…”
    Get full text
    Article
  2. 222

    Procalcitonin and High APACHE (Acute Physiological and Chronic Health Evaluation) Level Are Associated with the Course of Acute Kidney Injury in Patients with SARS-CoV-2 by Jorge Andrade Sierra, Claudia Delgado Astorga, Miriam Gabriela Nava Vargas, Enrique Rojas Campos, Kevin Javier Arrelano Arteaga, Karla Hernández Morales, Carlos A. Andrade Castellanos, Antonio de Jesús Andrade-Ortega, Luis Gerardo González Correa

    Published 2022-01-01
    “…The development of AKI was associated with higher phosphate (p=0.002) (RR 1.39, CI 95% 1.13–1.72), high procalcitonin levels at hospital admission (p=0.005) (RR 2.09, CI 95% 1.26–3.50), and high APACHE scores (p=0.011) (RR 2.0, CI 95% 1.17–3.40). The survival analysis free of AKI according to procalcitonin levels and APACHE scores demonstrated a lower survival in patients with procalcitonin >0.5 ng/ml (p=0.001) and APACHE >15 points (p=0.004). …”
    Get full text
    Article
  3. 223

    Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer by Yongjian Lin, Fu Gan, Xiaoyu He, Huachu Deng, Yong Li

    Published 2022-01-01
    “…The area under the receiver operating characteristic curve (AUC-ROC) reached above 0.9. Survival analysis suggested that when the Ferr-LPM score was higher, the overall survival (OS) of patients within this group was shorter. …”
    Get full text
    Article
  4. 224

    Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemotherapy: incorporating immune-inflammation scores and coagulation... by Yifan Yang, Shaoqi Zong, Yongqiang Hua

    Published 2025-01-01
    “…Firstly, the optimal cutoff values for continuous variables were obtained in the training cohort. Then, survival analysis was performed to evaluate the impact of immune-inflammatory scores neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and coagulation indicators prothrombin time (PT), fibrinogen (FIB), and D-dimer on the overall survival (OS) of patients. …”
    Get full text
    Article
  5. 225

    Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study by Pallav Gupta, Vinant Bhargava, Manish Malik, Anurag Gupta, Anil K. Bhalla, Ashwini Gupta, Vaibhav Tiwari, Devinder S. Rana, Ramesh L. Sapra

    Published 2023-07-01
    “…Patient and renal survival were compared using Kaplan-Meier survival analysis. Results: ANCA negative PICN patients were younger (44.9 ± 16.5 years vs 53.6 ± 15.1 years, P = 0.049). …”
    Get full text
    Article
  6. 226

    Expression and prognosis of cellular senescence genes in head and neck squamous cell carcinoma by Chen Feng, Lijuan Zhu, Wei Mao, Pin Dong, Xinwei Chen

    Published 2025-01-01
    “…Analyses included survival analysis, ROC curve analysis, risk curve analysis, independent prognostic analysis and model validation for clinical grouping. …”
    Get full text
    Article
  7. 227
  8. 228

    Comorbidities, long‐term outcome and poststroke epilepsy associated with ischemic stroke – A multicenter observational study of 125 dogs by Cecilia‐Gabriella Danciu, Rita Gonçalves, Carrete Jordina Caldero, Christoforos Posporis, Javier Espinosa, Steven deDecker, Hanne Gredal, Sophie Elizabeth Wyatt

    Published 2025-01-01
    “…Overall median survival time for dogs with a comorbidity was 482 days (range, 1‐3013) and 907 days (range, 1‐3027) in dogs without comorbidities (Kaplan‐Meier survival analysis P = .602). Twenty‐four dogs (19.2%) had a suspected stroke recurrence and a total of 8/109 dogs (7.3%) developed poststroke epilepsy. …”
    Get full text
    Article
  9. 229

    Modeling Survival Time to Death among Stroke Patients at Jimma University Medical Center, Southwest Ethiopia: A Retrospective Cohort Study by Bikiltu Wakuma Negasa, Teramaj Wongel Wotale, Mesfin Esayas Lelisho, Legesse Kassa Debusho, Kibrealem Sisay, Wubishet Gezimu

    Published 2023-01-01
    “…The Cox proportional hazard model and the accelerated failure time model were used to analyze the survival analysis of stroke patients using R software. …”
    Get full text
    Article
  10. 230

    Hypnotics' association with mortality or cancer: a matched cohort study by Daniel F Kripke, Lawrence E Kline, Robert D Langer

    Published 2012-02-01
    “…This study extends previous reports associating hypnotics with excess mortality.Setting A large integrated health system in the USA.Design Longitudinal electronic medical records were extracted for a one-to-two matched cohort survival analysis.Subjects Subjects (mean age 54 years) were 10 529 patients who received hypnotic prescriptions and 23 676 matched controls with no hypnotic prescriptions, followed for an average of 2.5 years between January 2002 and January 2007.Main outcome measures Data were adjusted for age, gender, smoking, body mass index, ethnicity, marital status, alcohol use and prior cancer. …”
    Get full text
    Article
  11. 231

    A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression by Nur Fatinazwa Mohd Faizal, Saptarsi Shai, Bansi P. Savaliya, Lee Peng Karen-Ng, Rupa Kumari, Rahul Kumar, Vui King Vincent-Chong

    Published 2025-01-01
    “…As the Cancer Genome Atlas (TCGA) dataset is available in HNSCC, the survival analysis prognosis of OSCC patients based on the TCGA dataset for discovering gene expression-based prognostic biomarkers is limited. …”
    Get full text
    Article
  12. 232

    Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis by Yuanshan Cui, Zhongbao Zhou, Yumeng Chai, Yong Zhang

    Published 2021-01-01
    “…The analysis of the ROC curve indicated that GSDMB had an AUC value of 0.820 to distinguish between ccRCC tissues and adjacent normal controls. Kaplan-Meier survival analysis indicated that ccRCC patients with high GSDMB had a poorer prognosis compared to those with low GSDMB (P<0.001). …”
    Get full text
    Article
  13. 233

    Prognostic determinants and functional role of PIK3C2G in stage IIb-IIIa lung adenocarcinoma: insights from clinical and molecular analyses by Chao Gao, Jiaqi Zhang, Xin Du, Xuehan Gao, Xiayao Diao, Ke Zhao, Yeye Chen, Shanqing Li

    Published 2025-01-01
    “…Functional experiments in A549 lung adenocarcinoma cells were performed to evaluate the role of the significant genes in tumor progression through cell proliferation, migration, invasion, apoptosis, and cell cycle assays.ResultsThe survival analysis of 877 stage IIb and IIIa lung adenocarcinoma cases revealed significant differences in clinical characteristics and outcomes. …”
    Get full text
    Article
  14. 234

    A retrospective study to understand the differences in maternal mortality among women admitted in critical and stable conditions in Malawi by David Lissauer, James Chirombo, Nara Tagiyeva-Milne, Jennifer Riches, Rosemary Bilesi, Lumbani Makhaza, Laura Munthali, Malangizo Mbewe

    Published 2025-01-01
    “…We performed descriptive analyses, stratified by condition on admission, to identify differences in case characteristics between the two groups, and an exploratory survival analysis, to understand the differences in time to death since admission. …”
    Get full text
    Article
  15. 235

    YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer by Ling-Chen Li, Xie-Wan Chen, Ling Fang, Chun-Li Jian, Yong-Xin Yu, Xing-Yun Liao, Jian-Guo Sun

    Published 2023-01-01
    “…By graph learning-based dimensionality reduction analysis, the immune landscape was visualized. Moreover, survival analysis was performed to verify the predictive value of YAP1 in ICIs treatment for EGFR-mutant NSCLC population using Ren’s research data (NCT03513666). …”
    Get full text
    Article
  16. 236

    Dissecting macrophage heterogeneity and kaempferol in lung adenocarcinoma: a single-cell transcriptomic approach and network pharmacology by Laiyi Wan, Wentao Hao, Leilei Li, Lin Wang, Yanzheng Song

    Published 2025-01-01
    “…Network pharmacology highlighted active TCM ingredients, including quercetin, isorhamnetin, and kaempferol, targeting genes related to macrophage function. Survival analysis implicated AHSA1, CYP1B1, SPP1, and STAT1 as prognostically significant factors. …”
    Get full text
    Article
  17. 237

    CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence by Zijian Qiu, Jiaji Wu, Guanchao Pang, Xia Xu, Jun Lin, Pingli Wang

    Published 2025-01-01
    “…Immunohistochemical (IHC) staining was carried out using a CD34 polyclonal antibody to determine intratumoral MVD, and the relationship of CD34-MVD with the clinicopathological characteristics and survival time of LUAD patients was analyzed.ResultsCD34-MVD was associated with tumor size, lymph node metastasis, tumor recurrence, and patient survival status; patients with tumor size ≤3 cm (P = 0.015), negative for lymph node metastasis (P = 0.049), no tumor recurrence (P = 0.021), and survival (P = 0.042) had higher MVD. Survival analysis suggested that patients with high MVD had higher disease-free survival (log-rank P = 0.005) and overall survival (log-rank P = 0.004) compared to patients with low MVD. …”
    Get full text
    Article
  18. 238

    Development of metastasis and survival prediction model of luminal and non-luminal breast cancer with weakly supervised learning based on pathomics by Hui Liu, Linlin Ying, Xing Song, Xueping Xiang, Shumei Wei

    Published 2025-01-01
    “…These features served as the foundational input for developing a machine learning algorithm for metastasis analysis and a Cox regression model for survival analysis. Result Our results show that the Inception_v3 model shows a particularly robust patch recognition ability for estrogen receptor (ER) recognition. …”
    Get full text
    Article
  19. 239

    Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage by Ning Du, Boxiang Zhang, Yunfeng Zhang

    Published 2023-01-01
    “…VRK1 was highly expressed in both LUSC tissues and cells. Survival analysis showed that the overall survival of LUSC patients with high VRK1 expression was significantly lower than that of LUSC patients with low VRK1 expression (P=0.0026). …”
    Get full text
    Article
  20. 240

    Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan by M.A. Khan, A. Ismail, A. Ghafoor, N. Khan, N. Muzaffar, F. Zafar, A. Gupta, S. Foraida, S. Juneja, R. Fatima, A.W. Khan, S. Shahid, M.A. Khan

    Published 2024-11-01
    “…Descriptive statistics, survival analysis and binary logistic regression analysis were employed. …”
    Get full text
    Article